Kalaris Therapeutics, Inc.
KLRS
$4.75
$0.020.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -100.88% | -199.27% | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -100.00% | -76.54% | |||
| Total Other Non-Cash Items | 15.88% | 31.95% | |||
| Change in Net Operating Assets | -934.88% | 213.01% | |||
| Cash from Operations | -215.76% | -64.59% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | -100.00% | 50.21% | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 100.00% | 1,995,440.00% | |||
| Cash from Financing | -100.00% | 1,530.45% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -1,339.03% | 4,750.63% | |||